Texas’ marijuana policies have come under renewed scrutiny as critics question whether the state is devoting limited law enforcement resources to cannabis-related offenses while other states have moved toward adult-use legalization or broader medical cannabis programs.
Online discussions have also raised allegations that alcohol industry interests are influencing Texas’ approach to marijuana policy, though no evidence has been publicly verified showing that state leaders are restricting cannabis because of payments or improper influence from alcohol companies.
Give The People A Break
Many Texans frustrated with current cannabis restrictions argue that marijuana enforcement should be reconsidered and that adults should have greater freedom to use a product that is legal in some form in a growing number of states.
Texas continues to maintain one of the nation’s more restrictive cannabis frameworks, with a limited medical cannabis program and ongoing regulation of hemp-derived THC products, as The Dallas Express previously covered.
The debate continues over whether marijuana enforcement should remain a state priority, how cannabis should be regulated, and whether Texas’ policies align with evolving research and public opinion.
What Texas Law Currently Allows
Texas does not have a recreational marijuana program. The state operates a limited medical cannabis program through the Texas Compassionate Use Program (TCUP), administered primarily through the Texas Department of Public Safety, which licenses dispensing organizations and manages the patient registry. Under House Bill 46 (effective September 1, 2025), the program was expanded to include additional qualifying conditions such as chronic pain (severe continuous or intermittent pain lasting more than 90 days for which tetrahydrocannabinol is a viable treatment), traumatic brain injury, Crohn’s disease or other inflammatory bowel disease, and terminal illness or hospice/palliative care.
The program allows low-THC cannabis products subject to statutory limits, including a restriction that dispensing organizations may not provide a package or inhalation device containing more than one gram of total THC.
Texas does not permit traditional marijuana flower under TCUP or recreational cannabis sales, although HB 46 expanded allowable delivery methods to include certain inhalation methods. HB 46 requires DPS to increase the number of licensed dispensing organizations to 15, provided sufficient qualified applicants meet licensing requirements.
In recent years, and most recently effective July 31, 2026, Texas has moved to restrict certain intoxicating hemp-derived cannabinoids, including delta-8 THC products, after a Texas Supreme Court ruling upheld the Department of State Health Services’ authority to classify certain products as controlled substances.
Why Critics Say Texas Should Focus Elsewhere
Some critics argue that law enforcement resources should prioritize violent crime rather than marijuana-related offenses. Similar arguments have appeared in Texas cities considering changes to marijuana enforcement priorities.
For example, Houston voters may consider a proposed charter amendment that would direct police resources away from low-level marijuana enforcement offenses and toward other priorities. The proposal was submitted after organizers gathered enough signatures to potentially place the issue before voters.
The broader argument is that marijuana enforcement can consume police time, court resources, and taxpayer dollars. Supporters of reform often point to other states that have legalized marijuana while maintaining criminal penalties for other controlled substances.
However, Texas officials who support stricter enforcement have generally argued that marijuana and THC products remain a public health and safety concern, particularly because of concerns involving youth access, impaired driving, and unregulated products.
Are Officials Being Paid Off by Alcohol Companies?
Online claims have circulated suggesting that Texas’ restrictions on hemp-derived THC products are connected to campaign contributions from figures in the alcohol industry. Some of those claims point to donations from John L. Nau III, chairman of Silver Eagle Distributors, a Texas-based beer distributor that distributes Anheuser-Busch products and other beverages.
Campaign finance records compiled by Transparency USA show that John L. and Barbara Nau III contributed $500,000 to Gov. Greg Abbott on June 29, 2026, and $275,000 to Lt. Gov. Dan Patrick on the same date. The records list Nau’s employer as Silver Eagle Distributors LP.
However, campaign contributions alone do not establish that a donor influenced a specific policy decision or that lawmakers acted in exchange for financial support. No publicly available evidence reviewed for this article shows that Nau, Silver Eagle Distributors, or other alcohol industry interests directed Texas’ hemp regulations or that the state’s THC restrictions were enacted because of campaign donations.
What is actually driving Texas’ hemp debate?
Youth access
Gov. Abbott’s executive order stated that Texas needed stronger protections for children and directed agencies to address hemp-derived products.
Regulation concerns
Supporters of restrictions have argued that some hemp-derived THC products entered the market through the 2018 federal hemp law and were sold with limited oversight.
Public safety concerns
Officials have cited concerns involving:
- impaired driving,
- product labeling,
- potency,
- accidental consumption by children.
Economic concerns
Opponents of bans argue that the hemp industry represents thousands of businesses and jobs and that regulation would be preferable to prohibition.
The alcohol industry, cannabis industry, medical organizations, and other groups all participate in policy debates involving marijuana laws.
What Does Research Actually Say About Cannabis Benefits?
Supporters of expanded cannabis access often point to studies examining potential benefits for conditions ranging from chronic pain and chemotherapy-related nausea to sleep disorders and certain neurological symptoms. Researchers, however, caution that the strength of evidence varies significantly depending on the condition being studied.
A comprehensive review by the National Academies of Sciences, Engineering, and Medicine found conclusive or substantial evidence that cannabis or cannabinoids can be effective for certain medical uses, including chronic pain in adults, nausea and vomiting caused by chemotherapy, and patient-reported symptoms of multiple sclerosis-related spasticity.
The same review found moderate evidence that some cannabinoid treatments may improve short-term sleep outcomes among individuals with conditions such as chronic pain, fibromyalgia, multiple sclerosis, and certain sleep disorders.
Chronic Pain
Pain management remains one of the strongest areas of medical evidence supporting cannabinoid use.
The National Academies review concluded there is substantial evidence supporting cannabis or cannabinoids as an effective treatment option for chronic pain in adults.
Researchers have examined cannabinoids because compounds such as THC and cannabidiol (CBD) interact with the body’s endocannabinoid system, which plays a role in pain signaling, inflammation, and nervous system regulation.
However, medical experts continue to debate dosage, long-term effects, and whether cannabis should replace existing treatments or serve as an additional therapy.
PTSD and Anxiety
PTSD has become one of the most frequently cited reasons veterans and other patients seek medical cannabis.
The Department of Veterans Affairs notes that many veterans report using cannabis to manage PTSD symptoms, but scientific evidence does not establish cannabis as an effective PTSD treatment.
The 2023 VA/DoD Clinical Practice Guideline for the Management of PTSD recommends against using cannabis or cannabis derivatives to treat PTSD, citing insufficient evidence of efficacy from rigorous trials, known adverse effects, and associated risks such as potential worsening of symptoms with chronic use, elevated rates of cannabis use disorder, and other medical or psychiatric harms.
Providers are encouraged to screen for and discuss cannabis use, educate patients on these risks, and prioritize evidence-based trauma-focused therapies, which remain effective even among those who use cannabis.
Research into CBD has produced interest because laboratory and early clinical studies suggest CBD may affect biological pathways involved in anxiety, although evidence from large clinical trials remains limited.
Neurological Conditions
Cannabinoid-based medications have shown benefits in some neurological conditions.
For example, the Food and Drug Administration has approved certain cannabinoid-derived medications for specific seizure disorders, including Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.
The National Academies also found evidence supporting oral cannabinoids for certain multiple sclerosis-related spasticity symptoms.
Cancer Treatment Symptoms
Cannabinoids are not proven to cure cancer, but they have been studied for symptom management.
The National Academies found substantial evidence that oral cannabinoids are effective antiemetics for chemotherapy-induced nausea and vomiting.
Researchers continue studying whether cannabinoids may have other roles in cancer treatment, but current evidence does not establish cannabis as a cancer therapy.
Why Is Marijuana Legal in Some States but Restricted in Texas?
Marijuana policy varies widely because states have taken different approaches to balancing potential medical benefits, public safety concerns, criminal justice costs, and regulatory oversight.
Some states have legalized recreational marijuana, while others allow only limited medical programs. Texas has continued to take a more restrictive approach, emphasizing limits on THC content and tighter controls on cannabis-related products.
The fact that marijuana is legal in some states does not mean federal or medical authorities have determined it is universally safe or effective. At the same time, legalization in other states has contributed to ongoing debate about whether criminal penalties remain the best policy approach.
Will Texas Marijuana Policy Change?
Whether Texas changes course will likely depend on future legislative action, court decisions, public opinion, and research developments.
Recent disputes over hemp-derived THC regulations demonstrate that cannabis policy remains unsettled in Texas.
Provided by Dallas Express
